MetaADEDB 2.0 @ LMMD
Memantine
(BUGYDGFZZOZRHP-UHFFFAOYSA-N)
Structure
SMILES
CC12CC3CC(C1)(C)CC(C2)(C3)N
Type(s)
Approved; Investigational
ATC code(s)
N06DA52; N06DA53; N06DX01
Molecular Formula:
C12H21N
Molecular Weight:
179.302
Log P:
3.3944
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
1
TPSA:
26.02
CAS Number(s):
19982-08-2
Synonym(s)
1.
Memantine
2.
1,3-Dimethyl-5-aminoadamantane
3.
1-Amino-3,5-dimethyladamantane
4.
Axura
5.
D-145
6.
D145
7.
Ebixa
8.
Memantin
9.
Memantine Hydrochloride
10.
Namenda
11.
D 145
External Link(s)
MeSHD008559
PubChem Compound4054
BindingDB50062599
ChEBI64312
CHEMBLCHEMBL807
DrugBankDB01043
DrugCentral1679
IUPHAR/BPS Guide to PHARMACOLOGY4253
KEGGcpd:C13736
dr:D08174
Therapeutic Target DatabaseD01JEU
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product use issueFAERS: 31US FAERS
2SomnolenceFAERS: 18SIDER
US FAERS
3EpilepsyFAERS: 14US FAERS
4Pulmonary EmbolismFAERS: 14SIDER
US FAERS
5Accidental overdoseFAERS: 11OFFSIDES
US FAERS
6DeliriumFAERS: 1118303133CTD
SIDER
US FAERS
7DizzinessFAERS: 1112409683CTD
OFFSIDES
SIDER
US FAERS
8Medication ErrorFAERS: 11US FAERS
9AgitationFAERS: 10SIDER
US FAERS
10Product substitution issueFAERS: 9US FAERS
11Urinary tract infectionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
12DementiaFAERS: 818413635
19155749
CTD
US FAERS
13FatigueFAERS: 8OFFSIDES
SIDER
US FAERS
14SyncopeFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15AstheniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
16No adverse eventFAERS: 7US FAERS
17VertigoFAERS: 7SIDER
US FAERS
18Visual ImpairmentFAERS: 7SIDER
US FAERS
19Wrong technique in drug usage processFAERS: 7US FAERS
20ConstipationFAERS: 6SIDER
US FAERS
21DisorientationFAERS: 5SIDER
US FAERS
22FractureFAERS: 5SIDER
US FAERS
23HypoxiaFAERS: 5US FAERS
24Memory impairmentFAERS: 5US FAERS
25OverdoseFAERS: 5US FAERS
26Splenic InfarctionFAERS: 5US FAERS
27Unresponsive to stimuliFAERS: 5US FAERS
28AnxietyFAERS: 4SIDER
US FAERS
29Cerebrovascular accidentFAERS: 4SIDER
US FAERS
30Drug dispensing errorFAERS: 4US FAERS
31IncontinenceFAERS: 4OFFSIDES
US FAERS
32Incorrect dose administeredFAERS: 4US FAERS
33MalaiseFAERS: 4SIDER
US FAERS
34Psychomotor skills impairedFAERS: 4US FAERS
35Therapy cessationFAERS: 4US FAERS
36Weight decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
37Activities of daily living impairedFAERS: 3US FAERS
38AmnesiaFAERS: 320170739CTD
SIDER
US FAERS
39BradycardiaFAERS: 3
Canada Vigilance: 1
18500725CTD
SIDER
Canada Vigilance
US FAERS
40Cerebral InfarctionFAERS: 3SIDER
US FAERS
41Drug ineffectiveFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
42HeadacheFAERS: 3SIDER
US FAERS
43IncoherentFAERS: 3US FAERS
44Intentional self-injuryFAERS: 3US FAERS
45Mental status changesFAERS: 3OFFSIDES
SIDER
US FAERS
46MyoclonusFAERS: 317632233
18303133
CTD
SIDER
US FAERS
47Ophthalmic vein thrombosisFAERS: 3US FAERS
48Violence-related symptomFAERS: 3US FAERS
49AlopeciaFAERS: 2SIDER
US FAERS
50Atrioventricular BlockFAERS: 2SIDER
US FAERS
51Blood creatine phosphokinase increasedFAERS: 2US FAERS
52CholestasisFAERS: 218413635CTD
US FAERS
53ChoreaFAERS: 2US FAERS
54Cogwheel RigidityFAERS: 2US FAERS
55Device information output issueFAERS: 2US FAERS
56Drug withdrawal syndromeFAERS: 2US FAERS
57DysarthriaFAERS: 2US FAERS
58DyspepsiaFAERS: 2SIDER
US FAERS
59DystoniaFAERS: 2US FAERS
60Feeling abnormalFAERS: 2SIDER
US FAERS
61General physical health deteriorationFAERS: 2US FAERS
62HypotensionFAERS: 2SIDER
US FAERS
63LethargyFAERS: 2OFFSIDES
SIDER
US FAERS
64Lower respiratory tract infectionFAERS: 2US FAERS
65MarasmusFAERS: 2US FAERS
66NauseaFAERS: 2SIDER
US FAERS
67PneumoniaFAERS: 2SIDER
US FAERS
68Product administration interruptedFAERS: 2US FAERS
69Slow speechFAERS: 2US FAERS
70Trifascicular blockFAERS: 2US FAERS
71Urinary RetentionFAERS: 2SIDER
US FAERS
72AbasiaFAERS: 1US FAERS
73AgeusiaFAERS: 1US FAERS
74AkathisiaFAERS: 1US FAERS
75Alanine Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
76Altered state of consciousnessFAERS: 1SIDER
US FAERS
77AngerFAERS: 1OFFSIDES
US FAERS
78Aspartate Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
79AsphyxiaFAERS: 1US FAERS
80Blood glucose increasedFAERS: 1US FAERS
81CarcinomaFAERS: 1US FAERS
82Cardiac ArrestFAERS: 1SIDER
US FAERS
83Cardiac DeathFAERS: 1US FAERS
84Cell DeathFAERS: 1US FAERS
85Chest discomfortFAERS: 1US FAERS
86CholecystitisFAERS: 1US FAERS
87CholelithiasisFAERS: 1SIDER
US FAERS
88ChromaturiaFAERS: 1OFFSIDES
US FAERS
89ColitisFAERS: 1SIDER
US FAERS
90Conduct DisorderFAERS: 1US FAERS
91Corneal dystrophyFAERS: 1US FAERS
92Corneal graft rejectionFAERS: 1US FAERS
93CystitisFAERS: 1SIDER
US FAERS
94Delusional disorder, persecutory typeFAERS: 1US FAERS
95Depressed Level of ConsciousnessFAERS: 1SIDER
US FAERS
96DiplopiaFAERS: 1OFFSIDES
SIDER
US FAERS
97Disease recurrenceFAERS: 1OFFSIDES
US FAERS
98Drug administration errorFAERS: 1US FAERS
99Drug prescribing errorFAERS: 1US FAERS
100DysphemiaFAERS: 1US FAERS
101DysphoniaFAERS: 1US FAERS
102EczemaFAERS: 1SIDER
US FAERS
103Endothelial dysfunctionFAERS: 1US FAERS
104FormicationFAERS: 1US FAERS
105GangreneFAERS: 1US FAERS
106Gastric ulcerFAERS: 1SIDER
US FAERS
107Genital infection fungalFAERS: 1US FAERS
108Hallucinations, mixedFAERS: 1US FAERS
109Hypertensive crisisFAERS: 1US FAERS
110Hyperviscosity syndromeFAERS: 1US FAERS
111ImmobileFAERS: 1US FAERS
112Impaired work abilityFAERS: 1US FAERS
113InfectionFAERS: 1SIDER
US FAERS
114Intestinal ObstructionFAERS: 1US FAERS
115Limb injuryFAERS: 1US FAERS
116Loss of personal independence in daily activitiesFAERS: 1US FAERS
117LymphadenopathyFAERS: 1US FAERS
118Malignant neoplasm progressionFAERS: 1US FAERS
119Mouth swellingFAERS: 1US FAERS
120MyalgiaFAERS: 1SIDER
US FAERS
121Myocardial InfarctionFAERS: 1SIDER
US FAERS
122NasopharyngitisFAERS: 1SIDER
US FAERS
123Neutrophil count decreasedFAERS: 1US FAERS
124NystagmusFAERS: 1US FAERS
125PancreatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
126Peripheral swellingFAERS: 1US FAERS
127Peripheral venous diseaseFAERS: 1US FAERS
128PhlebitisFAERS: 1SIDER
US FAERS
129Physical assaultFAERS: 1US FAERS
130Poor peripheral circulationFAERS: 1US FAERS
131PregnancyFAERS: 1US FAERS
132Product label confusionFAERS: 1US FAERS
133Psychiatric symptomFAERS: 1US FAERS
134Quality of life decreasedFAERS: 1US FAERS
135RestlessnessFAERS: 1US FAERS
136Sinoatrial BlockFAERS: 1US FAERS
137Sleep TalkingFAERS: 1US FAERS
138Soft tissue necrosisFAERS: 1US FAERS
139Suicide attemptFAERS: 1SIDER
US FAERS
140T-Cell LymphomaFAERS: 1US FAERS
141TachycardiaFAERS: 1SIDER
US FAERS
142Therapy partial responderFAERS: 1US FAERS
143ThrombocytopeniaFAERS: 1SIDER
US FAERS
144Tooth LossFAERS: 1US FAERS
145Toxicity to various agentsFAERS: 1US FAERS
146Urinary IncontinenceFAERS: 1SIDER
US FAERS
147Ventricular arrhythmiaFAERS: 1SIDER
US FAERS
148VomitingFAERS: 1SIDER
US FAERS
149White blood cell count decreasedFAERS: 1US FAERS
150Wrong technique in product usage processFAERS: 1US FAERS
151Abdominal PainSIDER
152Abdominal adhesionsOFFSIDES
153Abnormal visionSIDER
154AbscessSIDER
155AbuseOFFSIDES
156Acid refluxOFFSIDES
157Acute Coronary SyndromeSIDER
158AdnexitisOFFSIDES
159Adrenal massOFFSIDES
160Aggressive reactionSIDER
161AgranulocytosisSIDER
162Alcohol interactionOFFSIDES
163Alcohol-Induced Disorders29800586CTD
164Anal cancer metastaticOFFSIDES
165Angina PectorisSIDER
166Angiogram abnormalOFFSIDES
167AnhedoniaOFFSIDES
168AnorexiaOFFSIDES
SIDER
169Anticoagulation drug level above therapeuticOFFSIDES
170AnuriaCanada Vigilance: 1Canada Vigilance
171Aortic Valve StenosisSIDER
172ApathySIDER
173AphasiaSIDER
174Application site ulcerOFFSIDES
175ArteriosclerosisSIDER
176ArthralgiaSIDER
177Arthritis aggravatedSIDER
178ArthritisSIDER
179ArthropathySIDER
180Arthropod biteOFFSIDES
181AsthmaSIDER
182Ataxia10215643
30682440
CTD
SIDER
183AtelectasisOFFSIDES
SIDER
184Atrial FibrillationSIDER
185Atrial arrhythmiaSIDER
186AuraOFFSIDES
187Auricular swellingOFFSIDES
188Autistic Disorder17690064CTD
189Autonomic neuropathyOFFSIDES
190Back PainSIDER
191Bacterial sepsisOFFSIDES
192Band neutrophil count increasedOFFSIDES
193Basal cell carcinomaSIDER
194BelligerenceOFFSIDES
195Bilirubin conjugated increasedOFFSIDES
196Bladder adenocarcinoma stage unspecifiedOFFSIDES
197Bladder discomfortOFFSIDES
198Bladder painSIDER
199Bladder prolapseOFFSIDES
200BlepharitisSIDER
201Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
202Blood alkaline phosphatase increasedSIDER
203Blood and lymphatic system disordersSIDER
204Blood cortisol decreasedOFFSIDES
205Blood creatinine increasedSIDER
206Blood glucose decreasedOFFSIDES
207Blood iron decreasedOFFSIDES
208Blood thyroid stimulating hormone increasedSIDER
209Blood urea increasedSIDER
210Blurred visionOFFSIDES
211Body fat disorderOFFSIDES
212Bone erosionOFFSIDES
213Bone painOFFSIDES
SIDER
214Bowel movement irregularityOFFSIDES
215Brain Injuries27655295CTD
216Brain natriuretic peptide decreasedOFFSIDES
217Breast discomfortOFFSIDES
218Breast necrosisOFFSIDES
219Bronchial HyperreactivitySIDER
220BronchitisSIDER
221BronchospasmSIDER
222Bullous eruptionSIDER
223BursitisSIDER
224CD4 lymphocytes increasedOFFSIDES
225Cardiac HypertrophyOFFSIDES
226Cardiac enzymes increasedOFFSIDES
227Cardioactive drug level above therapeuticOFFSIDES
228Cardioactive drug level increasedOFFSIDES
229CardiomegalySIDER
230Carpal Tunnel SyndromeSIDER
231Catalepsy12762595CTD
232CataractSIDER
233CellulitisOFFSIDES
SIDER
234Chemical and Drug Induced Liver Injury18413635CTD
235Chest PainSIDER
236ChillsSIDER
237Chronic Obstructive Airway DiseaseOFFSIDES
238Cognition Disorders21741993CTD
239Cognitive deteriorationOFFSIDES
240Completed SuicideSIDER
241Complication of device insertionOFFSIDES
242ConfabulationOFFSIDES
243Confusion15889961CTD
244ConjunctivitisSIDER
245Corneal OpacitySIDER
246Coronary Artery DiseaseSIDER
247Creatinine increasedSIDER
248CryingOFFSIDES
SIDER
249CystoceleOFFSIDES
250DeafnessOFFSIDES
SIDER
251Decreased LibidoOFFSIDES
252Deep Vein ThrombosisSIDER
253DehydrationSIDER
254Dementia, Vascular12409683CTD
255Dental abscessOFFSIDES
256Dental cariesOFFSIDES
SIDER
257DermatitisSIDER
258Developmental Disabilities17016714CTD
259Device malfunctionOFFSIDES
260Diabetes MellitusSIDER
261Diabetes mellitus exacerbatedSIDER
262Diabetic RetinopathyOFFSIDES
263DiscomfortSIDER
264Disease complicationOFFSIDES
265Disturbance in sexual arousalSIDER
266DiverticulitisSIDER
267DiverticulumSIDER
268DrowsinessOFFSIDES
269Drug withdrawal headacheOFFSIDES
270Dry skinSIDER
271DysgeusiaSIDER
272Dyskinesia, Drug-Induced14642644
20014061
CTD
273DyslexiaOFFSIDES
274Dyspnoea exacerbatedOFFSIDES
275Dysthymic DisorderOFFSIDES
276DysuriaOFFSIDES
SIDER
277Economic problemOFFSIDES
278EctropionSIDER
279Electrocardiogram abnormal specificSIDER
280Electrocardiogram abnormalSIDER
281Electrocardiogram changeSIDER
282EmbolismSIDER
283EndarterectomyOFFSIDES
284Endotracheal intubation complicationOFFSIDES
285EnuresisOFFSIDES
286Eosinophil percentage increasedOFFSIDES
287EpistaxisSIDER
288Erectile dysfunctionSIDER
289EructationSIDER
290Erythema MultiformeSIDER
291Escherichia infectionCanada Vigilance: 1Canada Vigilance
292Essential HypertensionOFFSIDES
293ExcoriationSIDER
294Eye painSIDER
295Failure of implantOFFSIDES
296Failure to ThriveOFFSIDES
297Feeling of body temperature changeSIDER
298FibromyalgiaOFFSIDES
299Flat affectSIDER
300FlatulenceSIDER
301FlushingSIDER
302Foaming at mouthOFFSIDES
303Food PoisoningSIDER
304Food cravingOFFSIDES
305Full blood count decreasedOFFSIDES
306Gamma-Glutamyltransferase IncreasedSIDER
307GastritisSIDER
308GastroenteritisSIDER
309Gastrointestinal PainSIDER
310General nutrition disorderOFFSIDES
311GingivitisSIDER
312GlaucomaSIDER
313GoutOFFSIDES
SIDER
314Granulocyte count increasedOFFSIDES
315Hallucinations16087923
17030587
18294023
CTD
316HemiplegiaSIDER
317Hepatic calcificationOFFSIDES
318Hepatitis AOFFSIDES
319HepatitisSIDER
320HepatotoxicityOFFSIDES
321HerniaSIDER
322HidradenitisOFFSIDES
323HydrocephalusCanada Vigilance: 1Canada Vigilance
324Hyperalgesia20830263CTD
325HyperkeratosisSIDER
326HyperkinesiaSIDER
327HypersensitivitySIDER
328HypersomniaCanada Vigilance: 1Canada Vigilance
329Hypertension worsenedSIDER
330HyperthyroidismSIDER
331HypokinesiaSIDER
332HyporeflexiaSIDER
333HypothyroidismSIDER
334HysterectomyOFFSIDES
335IleusSIDER
336InfestationSIDER
337Inflicted injurySIDER
338Influenza-like symptomsSIDER
339InfluenzaSIDER
340Injection site cellulitisOFFSIDES
341Injection site scabOFFSIDES
342Intermittent ClaudicationSIDER
343Ischial neuralgiaSIDER
344LacerationOFFSIDES
345Lack of spontaneous speechOFFSIDES
346Lacrimation abnormal NOSSIDER
347LaryngitisSIDER
348LeukocytosisSIDER
349LeukopeniaSIDER
350Lewy Body Disease16087923
16340086
CTD
351Lyme DiseaseOFFSIDES
352LymphomaSIDER
353Macular degenerationSIDER
354MalnutritionSIDER
355Mastication disorderOFFSIDES
356MelanosisSIDER
357Memory Disorders

View details

CTD
358Meningioma surgeryOFFSIDES
359Mental impairmentOFFSIDES
360Mercury Poisoning, Nervous System18597911CTD
361Migraine Disorders18194287CTD
362Monocyte percentage decreasedOFFSIDES
363Monocyte percentage increasedOFFSIDES
364Mood swingsSIDER
365Motor Skills Disorders30682440CTD
366Movement Disorders8904651CTD
367Multiple SclerosisOFFSIDES
368Multiple drug overdose intentionalOFFSIDES
369Muscle Spasticity6891227CTD
370Muscle strainOFFSIDES
371Musculoskeletal chest painOFFSIDES
372Musculoskeletal discomfortSIDER
373MyopiaSIDER
374Necrosis18597911CTD
SIDER
375NephrolithiasisOFFSIDES
SIDER
376Nerve Degeneration18418360CTD
377NervousnessSIDER
378NeuralgiaSIDER
379Neuroleptic Malignant SyndromeSIDER
380NeuropathySIDER
381Neurosensory hypoacusisOFFSIDES
382NeutropeniaSIDER
383NevusSIDER
384No adverse effectOFFSIDES
385NumbnessSIDER
386OnychomycosisSIDER
387Oral fungal infectionOFFSIDES
388Organophosphate poisoning30682440CTD
389Osteitis DeformansOFFSIDES
390OsteopeniaOFFSIDES
391OsteoporosisSIDER
392OsteosclerosisOFFSIDES
393Otitis ExternaSIDER
394Otitis MediaSIDER
395Pain18806054CTD
SIDER
396PallorSIDER
397PalpitationsSIDER
398PancytopeniaSIDER
399Paradoxical drug reactionOFFSIDES
400ParanoiaSIDER
401Paranoid reactionSIDER
402Patellofemoral Pain SyndromeOFFSIDES
403Personality ChangeOFFSIDES
404Pharmaceutical product complaintOFFSIDES
405PharyngitisSIDER
406PneumothoraxSIDER
407Poisoning15824473CTD
408PolydipsiaSIDER
409PolyuriaSIDER
410Portal vein pressure increasedOFFSIDES
411Postoperative wound complicationOFFSIDES
412Product dose omissionCanada Vigilance: 1Canada Vigilance
413Product tamperingOFFSIDES
414Pruritus18413635CTD
SIDER
415Psychomotor Agitation17030587
18294023
CTD
416Psychoses, Substance-Induced1681331
15889961
CTD
417Pulmonary arterial hypertensionOFFSIDES
418Pulmonary thrombosisOFFSIDES
419PurpuraSIDER
420PyuriaSIDER
421Rash erythematousSIDER
422RectoceleOFFSIDES
423Renal Artery StenosisOFFSIDES
424Renal cystSIDER
425Respiratory FailureSIDER
426Respiratory InsufficiencySIDER
427Retinal DetachmentSIDER
428RhinitisSIDER
429RhinorrheaOFFSIDES
430SacroiliitisOFFSIDES
431Sarcoidosis19512963CTD
432SciaticaSIDER
433ScotomaOFFSIDES
434Seizures

View details

CTD
435Senile dementiaOFFSIDES
436SepsisSIDER
437Sexual activity increasedOFFSIDES
438ShockSIDER
439SinusitisSIDER
440Skin UlcerSIDER
441Skin lacerationOFFSIDES
442Skin neoplasm excisionOFFSIDES
443Sleep Wake Disorders19305123CTD
444Spasm30682440CTD
445Splenic cystOFFSIDES
446SpondylitisOFFSIDES
447Squamous cell carcinomaSIDER
448StaringOFFSIDES
449Stevens-Johnson SyndromeSIDER
450StuporSIDER
451Substance Withdrawal Syndrome10867961CTD
452Sudden deathSIDER
453SuicideSIDER
454Superficial ThrombophlebitisOFFSIDES
455Supraventricular tachycardiaSIDER
456Tardive DyskinesiaSIDER
457TensionSIDER
458Therapeutic response unexpectedOFFSIDES
459ThromboembolismSIDER
460ThrombophlebitisSIDER
461TinnitusOFFSIDES
SIDER
462ToothacheSIDER
463Tremor30682440CTD
SIDER
464Trousseau's syndromeOFFSIDES
465Ulcerative stomatitisSIDER
466Umbilical herniaOFFSIDES
467UnderweightOFFSIDES
468Urinary tract infection pseudomonalOFFSIDES
469Urine flow decreasedOFFSIDES
470Urine output increasedSIDER
471UrticariaSIDER
472Vascular purpuraSIDER
473Venous ThrombosisSIDER
474Vibration test abnormalOFFSIDES
475Vulvovaginal mycotic infectionOFFSIDES
476XerophthalmiaSIDER
477effusionOFFSIDES
478jaundice18413635CTD
479muscle injuryOFFSIDES
480nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.